Nuzenio

Mayne Pharma Group

Mayne Pharma Group news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 14 latest news signals 7 publisher sources 100/100 entity strength

Latest news

Inside Mayne Pharma’s (ASX:MYX) Latest Price Move and What Healthcare Investors Are Watching - KalkineKalkine · Fri, 07 Aug 2026 08:05:00 GMT MYX:ASX Announcement - Mayne Pharma Bioshares Summit Presentation - 05 Aug 2026 - Market IndexMarket Index · Thu, 06 Aug 2026 03:08:29 GMT MYX:ASX Announcement - Non-Executive Director appointment - 05 Aug 2026 - Market IndexMarket Index · Thu, 06 Aug 2026 03:06:40 GMT Mayne Pharma (ASX:MYX) Faces Board Pressure as Investors Push for Strategic Reset After Takeover Collapse - KalkineKalkine · Thu, 06 Aug 2026 02:36:00 GMT Mayne Pharma Group Reports Lapse of 24,860 Performance Rights - KalkineKalkine · Wed, 05 Aug 2026 07:16:57 GMT Mayne Pharma Group Announces Expiry of 24,860 Performance Rights Effective July 30, 2026 - Kalkine MediaKalkine Media · Wed, 05 Aug 2026 07:16:57 GMT Mayne Pharma Group Issues 161,465 Ordinary Shares Following Performance Rights Conversion - KalkineKalkine · Wed, 05 Aug 2026 07:16:57 GMT MYX:ASX Announcement - Mayne Pharma to present at the 20th Bioshares Summit - 03 Aug 2026 - Market IndexMarket Index · Tue, 04 Aug 2026 01:07:30 GMT

Timeline

Fri, 07 Aug 2026 08:05:00 GMTInside Mayne Pharma’s (ASX:MYX) Latest Price Move and What Healthcare Investors Are Watching - Kalkine

Thu, 06 Aug 2026 03:08:29 GMTMYX:ASX Announcement - Mayne Pharma Bioshares Summit Presentation - 05 Aug 2026 - Market Index

Thu, 06 Aug 2026 03:06:40 GMTMYX:ASX Announcement - Non-Executive Director appointment - 05 Aug 2026 - Market Index

Thu, 06 Aug 2026 02:36:00 GMTMayne Pharma (ASX:MYX) Faces Board Pressure as Investors Push for Strategic Reset After Takeover Collapse - Kalkine

Wed, 05 Aug 2026 07:16:57 GMTMayne Pharma Group Reports Lapse of 24,860 Performance Rights - Kalkine

Wed, 05 Aug 2026 07:16:57 GMTMayne Pharma Group Announces Expiry of 24,860 Performance Rights Effective July 30, 2026 - Kalkine Media

Related explainers

HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.

Connected entities

MYX9 live mentions ASX Announcement8 live mentions ASX6 live mentions Aug6 live mentions Mayne Pharma6 live mentions Market Index MYX4 live mentions Market Index Market4 live mentions Index4 live mentions Kalkine Mayne Pharma4 live mentions Bioshares Summit4 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Mayne Pharma Group.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

7 distinct publisher/source names are currently connected to this entity page.